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LOW-DOSE PRETREATMENT FOR RADIATION THERAPY
Richard Blankenbecler  Professor emeritus, Stanford Linear Accelerator
Center, Stanford University, Stanford CA; Adjunct Professor of Physics, Virginia
Tech, Blacksburg VA; Adjunct Fellow, Nevada Cancer Institute, Las Vegas NV
 In radiotherapy, a large radiation dose must be applied to both cancer and neighbor-
ing healthy cells. Recent experiments have shown that a low dose of ionizing radiation
turns on certain protective mechanisms that allow a cell to better survive a subsequent
high dose of radiation. This adaptive response can have important and positive conse-
quences for radiotherapy. This paper describes a simple change in treatment procedures
to make use of these beneficial effects. A low dose applied only to the healthy cells will
probably produce some damage. However, it will also start the adaptive response which
will yield increased protection when the large therapeutic dose is applied. The resultant
immediate damage will be thereby reduced as well as the probability that the high dose
therapy itself will induce a subsequent secondary cancer. After a brief historical review, the
effects of a low radiation dose on a canine cancer cell line will be discussed as well as tri-
als of the suggested pre-dose therapy on canine cancer patients undergoing standard radi-
ation therapy.
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INTRODUCTION
In this paper a preliminary report is presented on the results of a pro-
posed pre-dose protocol to be applied several hours before standard radi-
ation therapy (Blankenbecler 2005). The pre-dose is only applied to the
healthy cells surrounding a tumor in order to induce a protective adap-
tive response. Thus the healthy cells will be preconditioned for the sub-
sequent high dose while the cancer cells will not. The results of applying
this new therapy to canine patients will be reported. Preliminary results
on the genetic response of a canine cancer cell culture to low dose expo-
sure will also be discussed. A full discussion of the research will be given
in subsequent papers after all the data is analyzed (Blankenbecler, et al.,
2010 and Burke, et al., 2010). This paper is a written version of a talk given
at the Community Environmental Monitoring Program Workshop
(CEMP 2009) .
The study of the cellular and molecular responses induced by a low
dose of ionizing radiation can now be studied in detail using genomic
assays (Brooks 2005). Earlier technology was not sensitive enough to
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directly measure the genetic modulation from very low levels of ionizing
radiation (below ~ 10 cGy, roughly equivalent to several CT scans).
However, the beneficial effects of a pre-dose were evident from studies of
lifetime, cancer incidence and cancer latency.
Radiation therapy (RT), chemotherapy and surgical excision are
common methods used for treating tumors in humans and animals
(Freeman, et al., 2003). The success of radiation therapy in controlling or
eliminating a neoplasm is dependent on many factors (McEntee 2002).
Not all tumors can be successfully treated with RT. Some tumor cells are
radiation resistant due to an enhanced repair capability or an ability to
resist radiation-induced DNA damage.
RT is limited by the complications and damage to the normal tissues
surrounding the tumor. Thus the goal is to devise a therapy that delivers
a lethal dose to the cancerous cells but limits the damage to the nearby
healthy cells. This is accomplished at present by several methods includ-
ing dose fractionation and radiation beam design (Freeman, et al., 2003).
This paper will describe another tactic that can be added to these – the
use of a pre-dose to the healthy cells to utilize their adaptive response and
reduce their sensitivity to a subsequent large radiation dose
(Blankenbecler 2005). This effect can be used in several ways. This pro-
cedure allows the therapeutic dose to be increased, thereby improving
effectiveness and reducing the number of dose fractions and treatment
cost, or it can be used to reduce the side effects from the therapy by
decreasing patient discomfort. The probability that the high dose thera-
py itself will induce a late secondary cancer may also be reduced and its
latency increased.
BRIEF REVIEW
There have been many experiments studying the effects of low dose
radiation. One of the earliest references is the work by Russ (1909) who
showed that mice treated with low levels of radiation were more resistant
against bacterial disease. Recent advances in experimental techniques,
especially the ability to directly measure identifiable gene activity, have
led to a new level of understanding of the response of cells to low dose
radiation. The nonlinearity of the effect can be understood in terms of
gene modulation, both up and down, and the time dependence of pro-
tein production.
The Department of Energy has funded a special research effort aimed
at understanding the effects of low dose radiation. This program has
been reviewed by A. Brooks (2005). There is a compendium of papers
available on the web (Low Dose Site 2010). Most of the discussion
inspired by these experiments concerns the linear no threshold hypothe-
sis, the LNT. For a general review of the LNT see Cohen (2002).
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Yonezawa, et al., (1996), exposed ICR mice to 8 Gy of X-rays. Roughly
30% of the mice survived 30 days after exposure. However, when anoth-
er group was “pre-irradiated” with 5 cGy several hours before the 8 Gy
exposure, the survival rate increased to roughly 70%. In other experi-
ments, low dose “pre-exposure” delayed the onset of leukemia induced by
a subsequent exposure to a much larger dose of radiation. An adaptive
response arising from occupational exposure was studied by Barquinero,
et al., (1995).
Broome and co-workers (Broome, et al., 2002) administered low doses
of gamma radiation (0.1 cGy-50 cGy) to human skin cell tissue several
hours before exposure to a single high dose of 4 Gy gamma-radiation.
Using a micronucleus formation frequency assay, they found fewer chro-
mosomal micronuclei in cells pre-treated with low levels of radiation than
in cells that received no pretreatment. They attributed the observed
effects to increased efficiency of chromosomal repair in the cells pre-
treated with low dose radiation. It was also shown (Azzam, et al., 1994a,
1994b, 1996) that pretreatment of mouse embryonic cells in tissue cul-
ture with a low dose (0.1-10 cGy ) of gamma radiation reduced the rate of
neoplastic transformation of these cells following a higher (4 Gy) muta-
genic dose of radiation. They attributed these results to stimulation of
DNA repair mechanisms by low-dose radiation exposure. Mitchel and co-
workers (Mitchel, et al., 2002, 2003, Mitchel 2004), in a series of studies
using low dose and high dose exposures of cancer prone Trp53 het-
erozygous mice, demonstrated reduced rates of tumor formation and
longer periods of latency in tumor development when mice were pre-
treated with low doses of radiation prior to subsequently receiving a high
dose. However, the probability of eventual cancer formation was not
reduced.
Heller (2003) reviewed the results of research conducted at the
Lawrence Livermore Laboratory in which gene microarray data were
used to demonstrate the adaptive effects of low level irradiation in a vari-
ety of cell systems. It was shown that a low dose modulates several hun-
dred genes, including those involved in general cell repair. For further
research results see Coleman and Wyrobek (2006) and Yin, et al., (2003).
In vivo experiments at U. C. Davis on healthy human skin cell plugs,
Goldberg, et al., (2004) have demonstrated similar, but not quite identi-
cal, results for the cellular adaptive response in these complex mixture of
cell types.
Exposure experiments on rats have been carried out at the Chernobyl
accident site (Rodgers and Holmes 2008). Under a variety of conditions, a
pre-dose of 10 cGy was given at various dose rates up to 24 hours before a
challenge dose of 1.5 Gy. The frequency of micronucleus formation was
reduced by a factor of 2.6 following a pre-dose given at the highest dose rate
when compared to the same 1.5 Gy challenge dose without the pre-dose.
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The use of a whole body pre-dose before standard radiation therapy
has been suggested and discussed (Jin, et al., 2007). This technique has
the disadvantage of exposing the entire body to unnecessary radiation. It
also may trigger a protective adaptive response in the cancerous tissue
thereby reducing the kill probability from the standard treatment. More
study is needed to evaluate the full effects and potential of this protocol.
A general review of low dose effects has been given by Mitchel (2010).
It is important to study and discern whether low-level exposure always
constitutes a significant risk to patients, or if, in fact, under certain pre-
scribed conditions, some exposure can be protective. In particular, the
research described here is the first step in showing that the protective
effect can be used to reduce the damage to healthy cells from the high
exposure used in standard therapy.
CANINE MALIGNANCY
Radiation therapy (RT) is very useful in the treatment of certain oral
neoplasms in dogs. Oral malignancies in dogs may originate in several
source tissues. The most common types of malignancies – squamous cell
carcinoma, melanoma and fibrosarcoma – have been recognized and
well-studied for more than 30 years (Todoroff and Brody, 1979). In dogs,
these malignancies produce a variety of clinical signs and they often show
an aggressive growth pattern into soft and bony tissue. They may also
metastasize to distant sites. The suggested therapy for these tumors is a
combination of surgical resection/debulking and radiation therapy (RT).
Many oral tumors are relatively sensitive to radiation. The head and oral
cavity can be positioned to allow sharply focused radiation to be deliv-
ered, sparing other parts of the body from secondary irradiation.
Veterinary radiation oncologists are experienced in treating these tumors
and there are well- established and tested protocols for irradiating such
cancers and measuring the side effects.
CANINE CELL CULTURE IRRADIATION
The cell culture studies were undertaken to see if exposure to low
level (~0.1 Gy) γ-irradiation 24 hours prior to exposure to a higher level
of γ-radiation (~2.0 Gy) would affect expression of genes in cells that
might function to protect these cells from the effects of irradiation. We
chose to use a stable, well-characterized neoplastic cell line for these gene
modulation studies. A continuously-growing, stable canine squamous cell
carcinoma cell line (SCCA 2/88) was generously donated for use by Dr.
Elaine Müller and Prof. M. Suter (University of Bern Institute of Animal
Pathology, Längestrasse 122 CH-3012 Bern, Switzerland). Cells were cul-
tured in flasks and then subdivided into 25 ml. culture flasks for control,
radiation exposure, and analysis.
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A cobalt 60 γ-ray source was used to irradiate the cultures at a dose
rate of 7 cGy/min. The first control flask was not exposed to radiation.
The second flask was exposed to 10 cGy only. The third flask was exposed
to 10 cGy and 24 hours later received 2.0 Gy. The forth flask was exposed
to 2.0 Gy only. Cells were then harvested at selected times following “radi-
ation therapy” (1 hour, 6 hours, 24 hours, 48 hours, and 72 hours), stabi-
lized, and their mRNA isolated.
RNA was extracted from the irradiated tumor cells and hybridized on
Canine 2.0 gene chips from Affymetrix. Assays were performed in tripli-
cate to achieve uniformity of preparation and analysis. After quality
assessment of the arrays, the probe intensities were normalized (Lim, et
al., 2007) . Principal components analysis and hierarchical clustering
were used (Yeung and Ruzzo, 2001). Linear modeling of microarray data
analysis, LIMMA, was used to detect changes in gene expression (Smyth
2005) and was used on all samples to identify genes in which there was at
least a 2-fold difference in gene expression, either up-regulation or down-
regulation, based on mRNA levels. Approximately 20,000 non-redundant
predicted genes are assayed on the Affymetrix Canine GeneChip 2.0
Array.
At this juncture, only the 48 hour data has been analyzed and will be
described here. The analysis of the complete data set will be reported
later (Blankenbecler, et al., 2010). Exposure to 10 cGy had little effect on
tumor gene expression, two were up-regulated and one down-regulated.
Not unexpectedly, a large dose (2.0 Gy) of irradiation produced substan-
tial alterations in gene expression within 48 hours of exposure.
Comparing the control group with the 2.0 Gy group, it was found that
568 genes were up-regulated while 854 genes were down-regulated.
Comparing the 10 cGy group with the 2.0 Gy group, it was found that 523
genes were up-regulated while 740 genes were down-regulated. In com-
paring the control group with the (10 cGy +2.0 Gy) group, it was found
that 541 genes were up-regulated while 902 genes were down-regulated.
However, a substantially higher number of genes, 798, are up-regulated,
and a substantially lower number of genes, 509, are down-regulated,
when data from the (10 cGy+2.0 Gy) Group is compared with the 10 cGy
group.
There is a clear difference in gene regulation associated with low dose
pretreatment of cells and high dose effects. We have identified a set of 68
genes associated with control of heat-shock proteins and DNA-repair, and
then repeated LIMMA on these genes to identify changes associated with
the various exposures.
CANINE PATIENT TRIALS
Canine patients with oral cancers were examined and selected for the
study according to predefined criteria. Owners were informed that the
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objective of this study was to determine if a low level (0.1 Gy) exposure 24
hours before a standard course of fractionated radiotherapy would affect
gene expression and provide protection for the healthy cells surrounding
the tumor. Informed owner consent was obtained for participation in the
study. Standard veterinary and institutional animal care procedures were
followed throughout the trials.
Any dog with gross squamous cell carcinoma or acanthomatous epulis
was considered for the trial (Morrison 2002). Surgery and standard radio-
therapy were offered to the owners of all patients. A total of 8 dogs were
enrolled during the trial period. Test subjects and control subjects were
selected randomly from the pool. Five dogs had mandibular tumors and
3 dogs had maxillary tumors. Biopsies were taken from all patients. All
dogs had three-view thoracic radiographs prior to therapy. None of the
selected patients had evidence of metastatic spread. The patients were
anesthetized during all therapy sessions. Tumor dimensions were meas-
ured by calipers and the treatment fields were centered on the gross dis-
ease with 3 cm margins. The 4 patients receiving low-dose pretreatment
were given a single dose of 10 cGy of 6 MV x-ray radiation and delivered
to the field at a source-skin distance of 100 cm to the bolus. The tumor
was shielded with preformed lead blocks placed so as to prevent exposure
to the pretreatment dose.
Twenty-four hours later, the treatment course of 48 Gy in 16 x 300 cGy
fractions was started on all patients. As before, the patient was anes-
thetized and placed in position for treatment. Biopsies were obtained
from the tumor and a representative region of normal tissue in the treat-
ment field.
Following the biopsies, the treatment field was reestablished using
photographs and ink lines marked on the patient. No lead blocks were
used and the entire tumor was exposed to radiation. Each treatment frac-
tion consisted of 300 cGy delivered in a single session. Tumor response
and side effects were observed daily and recorded at the end of each
treatment week.
The biopsy procedure was repeated on the last day of therapy prior to
administration of the final treatment fraction. Normal tissue side effects
and tumor measurements were recorded. The radiation oncologist
administering therapy evaluated each patient for the presence or absence
of therapeutic effects on the tumor and for the presence or absence of
acute radiation side effects. A pre-determined scale for grading the sever-
ity of acute side effects was used to record data on each patient during the
course of therapy. Observations of patients and objective assessment of
condition occurred on a twice-daily basis throughout the course of thera-
py, and then at prescribed intervals following therapy. The importance of
photographic documentation following therapy was recognized in the
assessment of side effects, tumor growth, and patient progress.
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A standard veterinary pre-determined scale (0=none, 1=minimal,
2=moderate, 3=severe effects) was used for grading the severity of the side
effects for each patient during the course of the therapy. The observed
scores at the conclusion of the treatment for skin effects were (1,2,1,2:
average 1.5) for the pre-dose group and (3,1,3,2: average 2.25) for the
control group. The scores for side effects on the mucous membrane were
(1,2,2,2: average 1.75) for the pre-dose group and (3,2,2,2: average 2.25)
for the control group. Based on this limited data, the scoring of lesions of
the oral cavity following the fractionated RT showed a decrease in severi-
ty of distressful side effects in those dogs that had a low dose pretreatment
as compared to the control group. Experiments have not yet been per-
formed that test the effect of an increase in the per fraction dose follow-
ing the pre-dose treatment. If these prove to be effective, then the
decrease in the number of fractions and hence the number of times that
the dogs must be sedated could lead to substantial benefits in terms of
health, cost, safety, and recovery time.
CONCLUSIONS
Results of this small pilot study appear to indicate a cytoprotective
effect of low dose radiation (0.1 Gy) pretreatment of normal tissues
before standard fractionated therapy for oral tumors in dogs. These clin-
ical observations support the studies discussed above on canine squa-
mous cell carcinoma tissue cultures. Canine neoplasms can be a useful
model for human cancers since dogs suffer from essentially the same
types of natural cancers as humans but with quite different frequencies
that are also highly breed dependent, suggesting a genetic connection.
At the same time, these results are cautionary. More work is needed
to study the balance of effects between cytoprotection of normal tissues
and the RT effects on tumor tissues. In particular, the time dependence
of the adaptive response needs to be better determined in order to plan
an optimized treatment. The adaptive response at 24 and 48 hours is well
enough known that the low dose pretreatment could be applied with con-
fidence for radiotherapy protocols that use few fractions, such as gamma
knife or similar technologies. With a better understanding of the time
dependence, optimum protocols could be developed for multifraction
treatment schemes. The adaptive response of different cell types also
needs to be studied. However, the protective effect of the adaptive
response when a low dose is applied to the entire animal shows that the
response should be quite universal among cell types.
Taken together, this initial in vitro and in vivo work suggests that pro-
tocols can be developed and optimized that will minimize the acute and
late associated side effects from RT. This could substantially change how
radiotherapy is planned and performed, and provide methods to more
successfully treat patients.
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